drugset / Trial / NCT02435303

Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)

NCT02435303

Phase 2/3 Terminated 2 enrolled Asan Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Sildenafil is effective in the treatment of sustained pulmonary artery hypertension after corrected mitral valve disease.

Timeline

Start
2016-05
Primary completion
2018-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 20 mg